| abstract |
The object of the present invention is to provide a material which can be ingested safely and suppresses pigmentation in the skin. That is, the present invention relates to a skin pigmentation inhibitor characterized by using β-nicotinamide mononucleotide, a pharmacologically acceptable salt thereof, and a solvate thereof as an active ingredient. The present invention also relates to a health product containing the skin pigmentation inhibitor, and the ingestion of the health product is used to inhibit pigmentation in the skin. In addition, the present invention relates to a method of suppressing pigmentation in skin, which includes ingesting a skin pigmentation inhibitor. |